NCT01060904 2014-12-18A Phase 1 Study of Brentuximab Vedotin Combined With Multi-Agent Chemotherapy for Hodgkin LymphomaSeagen Inc.Phase 1 Completed51 enrolled
NCT00031902 2013-09-20Rituximab Plus Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's LymphomaNational Cancer Institute (NCI)Phase 1 Unknown